Sasoon Road
Sasoon Road
Hinjawadi
Wanworie

Neuro Trauma Unit

Precision in Emergency, Excellence in Recovery
Providing unparalleled medical experience and top-notch facilities, the NTU is a world-class workplace that guarantees high-quality medical care for conditions related to neurology, trauma, and stroke. Based on research and well-known publications, it is considered one of Pune’s best neurological hospital, with a history of innovation and excellence.
We are able to provide care for a wide range of illnesses thanks to our 48 operational beds, skilled staff, and innovative treatment regimen.
Our mission is to achieve clinical excellence, patient safety, and satisfaction by making quality an essential component of every aspect of our business operations.
n-precare

Pre-hospital care

n-paccident

Accident and emergency unit

n-trauma

Neuro trauma unit

n-rehabita

Neuro rehabilitation

Pre-hospital care​

Accident and emergency unit

Neuro trauma unit

Neuro rehabilitation

Neuro Trauma Intensive Care Unit Facilities

Multidisciplinary critical care
Level 1 Trauma care center
Our highly trained specialists provide treatment to complex stroke patients
Neuro intervention facility for STROKE / SAH / VST
State of art Neuro monitoring facilities.
Perioperative management of high-risk surgical patients
Advance haemodynamic suport facility
Epilepsy monitoring room facility
Bedside EEG monitoring facility
Contenouse EEG monitoring facility
POCUS (Point of care USG)facility.
CRRT / Bedside Dialysis
Therapeutic plasma exchange (TPE) facility.

Advanced invasive/non – invasive ventilatory support facility

Therapeutic plasma exchange (TPE) facility.

Services Complementing NTU Care Capacity…

NABH accreditation
Specialists and well-trained doctors – available round the clock
Nursing ratio 1:2, with well-trained and dedicated nurses
Clean, hygienic environment with strict infection control practices in place
Established Antibiotic stewardship program
Center of excellence for Organ Transplantation
Daily counseling sessions to update current condition of patients
Liberal and patient selective visiting hours for near dear ones.
Advance Neuro Rehabilitation program.
Dedicated Coordinator to bridge gap between relatives & Ntu staff
24 /7 Dietary services available with on demand menu facility.
Complimentary Locker / washroom / relax facilities for one accompanied relative.

Our Inspiration

Dr. Purvez Grant

Chairman & Managing Trustee

The Chief Cardiologist and Chairman of Cardiovascular Services at the hospital, Dr. Purvez Grant, is the pillar of the legacy of Ruby Hall Clinic. One of the most sought-after specialists in cardiology, Dr. Grant holds a slew of fellowships from some of the most prestigious establishments in the world, including the American College of Cardiology and the Royal Society of Medicine, UK, among others. Also, in recognition of his services to the medical field, Dr. P.K. Grant has been conferred several honours, including three national awards.

Mr. Behram Khodaiji

Chief Executive Officer

Mr. Behram considers leadership as a humble service role, and carries great pleasure and pride in serving people. His objective is to maintain and enhance the outstanding level of care delivered by the exceptional team of doctors, nurses, and paramedical staff at Ruby Hall Clinic. He strives to uphold the hospital’s legacy of patient-centred care and highest clinical standards, while continually progressing in medicine.
“Over the years, we have become one of the leading healthcare destinations nationally and globally, earning the trust of patients thanks to highly skilled medical experts and advanced technology. Today, we are more than just a place to go when you’re sick—we are a dependable resource to keep you and your loved ones healthy all year round. We take immense pride and responsibility for those who have confidence in our care”, he says.

Mr. Urvaksh Bhote

Chief Operating Officer

Mr. Urvaksh brings over 26 years of extensive expertise in global business operations, finance & accounting, change management, transformation, and operational excellence to our team. Before joining us, he served as the CEO and Board Member at DecisivEdge Technology Services India Pvt. Ltd. Mr. Urvaksh holds a bachelor’s in commerce and a master’s in business administration, specialising in finance. He is a certified project management professional from PMI, Certified Lean Six Sigma Green and Black Belt, and holds a diploma in import and export management and materials management.

Neuro Trauma Intensive Team

R S Wadia

MD, FICP, FIAN Mentor, Founder & Director, Stroke Unit

Dr. Sanjay Vhora

M.S. (surg.) M.Ch. (neurosurgery) Chairman & Founder Director, Neuro Trauma Unit

Dr. Sunil Bandishti

MD Medicine DM Neurology Head, Neuroscience Department

Dr. Kapil Zirpe

HOD, Director NTU

Dr. Sushma Gurav

Senior Consultant Incharge NTU II

Courses Available At NTU

Course Name Description No. of Seats Eligibility
Indian Diploma in Critical Care Medicine (IDCCM) One year course for MD/MS/DNB candidates and 2 years for Diploma candidates 8
  • Diploma in Anaesthesia/Diploma in Chest diseases.
  • MD Medicine/Chest/Anaesthesia
  • DNB Medicine/Chest/Anaesthesia
  • The base qualifications must be from an MCI recognised university
Indian Fellowship in Critical Care Medicine (IFCCM) One year fellowship course after completion of IDCCM 2 Duration of IFCCM is one year post IDCCM
FNCC (Fellowship in Neuro Critical Care) Course duration: 1 years 2
  • Diploma in Anaesthesia/Diploma in Chest diseases.
  • MD Medicine/Chest/Anaesthesia
  • DNB Medicine/Chest/Anaesthesia
  • The base qualifications must be from an MCI recognised university
ISCCM Diploma In Critical Care Nursing This course is designed to assist students in developing expertise and knowledge in the field of Critical care Nursing 8 GNM , B.Sc. Nursing, M. Sc. Nursing, PG Diploma
FNB Critical Care Course It is a two-year fellowship course after completion MD Medicine/Chest/Anaesthesia 2 Candidates are allotted from DNB board through central NEET PG examination
Fellowship in Neuro Critical Care (MUSH) Duration:01 Year 2
  • Diploma in Anaesthesia/Diploma in Chest diseases
  • MD Medicine/Chest/Anaesthesia
  • DNB Medicine/Chest/Anaesthesia
  • The base qualifications must be from an MCI recognised university

NTU Academics:

Courses Available At NTU

Course Name Description No. of Seats Eligibility
Indian Diploma in Critical Care Medicine (IDCCM) One year course for MD/MS/DNB candidates and 2 years for Diploma candidates 8
  • Diploma in Anaesthesia/Diploma in Chest diseases.
  • MD Medicine/Chest/Anaesthesia
  • DNB Medicine/Chest/Anaesthesia
  • The base qualifications must be from an MCI recognised university
Indian Fellowship in Critical Care Medicine (IFCCM) One year fellowship course after completion of IDCCM 2 Duration of IFCCM is one year post IDCCM
FNCC (Fellowship in Neuro Critical Care) Course duration: 1 years 2
  • Diploma in Anaesthesia/Diploma in Chest diseases.
  • MD Medicine/Chest/Anaesthesia
  • DNB Medicine/Chest/Anaesthesia
  • The base qualifications must be from an MCI recognised university
ISCCM Diploma In Critical Care Nursing This course is designed to assist students in developing expertise and knowledge in the field of Critical care Nursing 8 GNM , B.Sc. Nursing, M. Sc. Nursing, PG Diploma
FNB Critical Care Course It is a two-year fellowship course after completion MD Medicine/Chest/Anaesthesia 2 Candidates are allotted from DNB board through central NEET PG examination
Fellowship in Neuro Critical Care (MUSH) Duration:01 Year 2
  • Diploma in Anaesthesia/Diploma in Chest diseases
  • MD Medicine/Chest/Anaesthesia
  • DNB Medicine/Chest/Anaesthesia
  • The base qualifications must be from an MCI recognised university

Activities at NTU

blueUnion
  • Bed side clinics twice a week
  • Classroom teaching twice a week
  • Journal club once a week
  • Group Discussion twice a month
  • Case presentation once a week

For More Information

blueUnion

Courses Available At NTU

Sr. No. Contributors Years
1 The intensive care Outcome Network (ICON) Study 2012
2 Limitations and Problems in thrombolysis of acute stroke patient tertiary care experience, IJCCM 2015
3 Dengue infection with multi organ dysfunction: SOFA score, arterial lactate and albumin levels predictors of outcome. 2015
4 Intensive Care in INDIA: The Indian intensive care case mix and practice pattern study. IJCCM 2016
5 Survival or safety: Balancing act with colistin, Expert Commentary, Journal of Global infectious diseases 2016
6 Management of Potential Organ Donor: Indian Society of Critical Care Medicine (ISCCM) - Position Statement IJCCM 2017
7 Multi-center Observational Study to evaluate epidemiology and Resistance Patterns of Common ICU-infections. IJCCM 2017
8 "The impact of early tracheostomy in neurotrauma patients: A retrospective study" IJCCM 2017
9 Impact of stroke code: Rapid response team; An attempt to improve intravenous thrombolysis rate & to shorten door to needle time in Acute ischemic stroke. IJCCM 2018
10 Critical care Quality Up gradation Enabled by Space Technology (QUEST) IJCCM 2018
11 Practice Guidelines on Nutrition in critically ill: A Relook for Indian scenario- IJCCM 2018
12 Brain Death And Management Of Potential Organ Donor 2019
13 Practice Guidelines For Enteral Nutrition Management In Dysglycemic Critically Ill Patients: A Relook For Indian Scenario. 2019
14 ISCCM Guidelines for the Use of Non-invasive Ventilation in Acute Respiratory Failure in Adult ICUs. 2020
15 Indian Society of Critical Care Medicine Position Statement for Central Venous Catheterization and Management 2020. 2020
16 Tracheostomy in Adult Intensive Care Unit: An ISCCM Expert Panel Practice Recommendations. 2020
17 Methicillin-resistant Staphylococcus aureus in Intensive Care Unit Setting of India: A Review of Clinical Burden, Patterns of Prevalence, Preventive Measures, and Future Strategies. 2020
18 Indian Society of Critical Care Medicine Experts Committee Consensus Statement on ICU Planning and Designing, 2020. 2020
19 Opiate and Cerebral Atrophy. 2020
20 Cytokine storm in Novel Coronavirus Disease (COVID 19) : Expert Management Considerations 2020
21 Dilatational Percutaneous vs Surgical Tracheostomy in Intensive Care Unit: A practice pattern Observational Multicenter study (DISSECT) 2020
22 Current Approaches to COVID 19: Therapy and Prevention 2020
23 Airway Management and related procedures in Critically Ill COVID 19 patients: Position Statement of Indian Society of Critical Care Medicine 2020
24 Development of critical care medicine in India. 2020
25 Procalcitonin (PCT)-guided antibiotic stewardship in Asia-Pacific countries: adaptation based on an expert consensus meeting. 2020
26 Antimicrobial de-escalation in the critically ill patient and assessment of clinical cure: the DIANA study. 2020
27 Determination of Brain Death/Death by Neurologic CriteriaThe World Brain Death Project 2020
28 Increase in Cadaver Organ Donation Rate at a Tertiary Care Hospital: 23 Years of Experience 2020
29 Current approaches to COVID 19: Therapy and Prevention 2020
30 Airway Management and Related Procedures in Critically Ill COVID-19 Patients: Position Statement of the Indian Society of Critical Care Medicine 2020
31 Incidence of Medication Error in Critical Care Unit of a Tertiary Care Hospital: Where Do We Stand? 2020
32 Practice Implications for Acute Ischemic Stroke during the COVID-19 Pandemic for the Indian Scenario: Realistic and Achievable Recommendations by the Society of Neurocritical Care (SNCC), India 2020
33 Pathophysiological Mechanisms and Neurological Manifestations in COVID-19 2020
34 Consensus statement of ecological management of coronavirus disease 2019 (COVID-19): A Pragmatic Approach/Abstract 2020
35 Timing of Invasive Mechanical Ventilation and Mortality among Patients with Severe COVID-19-associated Acute Respiratory Distress Syndrome 2021
36 Age as Maestro or Solo Instrument in Opera of Death 2021
37 Cureus 2021
38 Intensive Care in India in 2018 to 2019: The Second Indian Intensive Care Case Mix and Practice Patterns Study 2021
39 A Real-world Study on Prescription Pattern of Fosfomycin in Critical Care Patients 2021
40 Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo-controlled phase 3 trial 2021
41 An artificial intelligence system for predicting mortality in COVID-19 patients using chest X-rays: a retrospective study 2021
42 Therapeutic Approaches in Modulating the Inflammatory and Immunological Response in Patients With Sepsis, Acute Respiratory Distress Syndrome, and Pancreatitis: An Expert Opinion Review 2021
43 Barotrauma, invasive ventilation, and timing of tocilizumab as predictors of mortality along with inflammatory markers and comorbidities in critically ill COVID-19 patients: A retrospective study 2021
44 A Retrospective Analysis of Risk Factors of COVID-19 Associated Mucormycosis and Mortality Predictors: A Single-Center Study 2021
45 The Second-vs First-wave COVID-19: More of the Same or a Lot Worse? A Comparison of Mortality between the Two Waves in Patients Admitted to Intensive Care Units in Nine Hospitals in Western Maharashtra 2021
46 Compass in COVID-19 Illness: Disseminated Intravascular Coagulation/Sepsis Induced Coagulopathy Scoring in Predicting Severity 2021
47 COVID-19 pandemic in India 2022
48 Prescription-Event Monitoring Study on Safety and Efficacy of Levonadifloxacin (Oral and I.V.) in Management of Bacterial Infections: Findings of Real-World Observational Study 2022
49 Prescription-Event Monitoring Study on Safety and Efficacy of Levonadifloxacin (Oral and I.V.) in Management of Bacterial Infections: Findings of Real-World Observational Study 2022
50 Case of Suspected SARS-CoV-2 Vaccine-induced Immune Thrombotic Thrombocytopenia (VITT): The Dilemma for Organ Donation 2022
51 Organ Donation after Circulatory Determination of Death in India: A Joint Position Paper 2022
52 CRITICAL CARE Theme: Neurocritical Care A BI-MONTHLY NEWSLETTER OF INDIAN SOCIETY OF CRITICAL CARE MEDICINE 2022
53 Recommendations for Evaluation and Selection of Deceased Organ Donor: Position Statement of ISCCM 2022
54 Pune ISCCM Covid ARDS Study Consortium (PICASo), is a multicentre retrospective cohort study to know effectiveness of NIRAD (Non-Invasive Respiratory Assist Devices) in avoiding invasive mechanical ventilation in COVID-19-associated severe Hypoxic respiratory failure. Data of 1201 patients from 12 institutes was analyzed. 2022
55 Retrospective Cohort Observational Study to compare the Effect of Mycobacterium w along with Standard of Care vs Standard of Care alone in critically ill COVID-19 Patients 2022
56 Dimethoate Self-poisoning-induced Severe Hypotension 2022
57 Indian Society of Critical Care Medicine Consensus Statement for Prevention of Venous Thromboembolism in the Critical Care Unit 2022
58 Guidelines for the Use of Procalcitonin for Rational Use of Antibiotics 2022
59 Indian Society of Critical Care Medicine Consensus Statement for Prevention of Venous Thromboembolism in the Critical Care Unit Executive Summary 2022
60 Ulinastatin Add-on to Standard of Care in Critically Ill COVID-19 Patients: A Multicenter, Retrospective Study 2023
61 The Curing Coma Campaign®: Concerns in the Indian Subcontinent 2023
62 Incidence, Subtypes, Risk factors, and Outcome of Delirium: A Prospective Observational Study from Indian Intensive Care Unit 2023
63 A National Survey on Coma Epidemiology, Evaluation and Therapy in India – Revisiting The Curing Coma® Campaign COME TOGETHER Survey 2023
64 Benchmarking Hospital Practices and Policies on Intrahospital Neurocritical Care Transport: The Safe-Neuro-Transport Study 2023
65 A Nationwide Survey on the Practice of End-of-life Care Issues in Critical Care Units in India 2023
66 Utility of Bedside Ultrasound Measurement of Optic Nerve Sheath Diameter as a Screening Tool for Raised Intracranial Pressure in Neurocritical Care: Prospective Observational Study 2023
67 Adverse Events during Intrahospital Transport of Critically Ill Patients: A Multicenter, Prospective, Observational Study (I-TOUCH Study) 2023

Social Events

Awards & Recognition

Articles

FAQs

The two forms of stroke are ischemic – blockage of a blood vessel supplying the brain, and hemorrhagic – bleeding into or around the brain. In an ischemic stroke, a blood clot blocks or plugs a blood vessel or artery in the brain. About 80 percent of all strokes are ischemic. In a hemorrhagic stroke, a blood vessel in the brain breaks and bleeds into the brain. About 20 percent of strokes are hemorrhagic.

When a stroke occurs, the blood supply to part of the brain is suddenly interrupted. Brain cells die when they no longer receive oxygen and nutrients from the blood or there is sudden bleeding into or around the brain.

Symptoms include sudden numbness or weakness, especially on one side of the body; sudden confusion or trouble speaking or understanding speech; sudden trouble seeing in one or both eyes; sudden trouble with walking, dizziness, or loss of balance or coordination; or sudden severe headache with no known cause. An easy way to remember the symptoms is F.A.S.T i.e. Facial Droop, Arm Weakness, Speech, Time

During a stroke, bystanders should know the signs and act in time. If you believe someone is having a stroke — if the person loses the ability to speak, to move an arm or leg on one side, or experiences facial paralysis on one side — call 108 immediately. Stroke is a medical emergency. Immediate stroke treatment may save someone’s life and enhance his or her chances for successful rehabilitation and recovery.

Ischemic strokes, the most common strokes, can be treated with a drug called tPA, which dissolves artery-obstructing clots. The window of opportunity to use TPA to treat stroke patients is 4.5 hrs, so the sooner stroke patients can get to the hospital to be evaluated and receive treatment, the better their outcome. Stroke patients who receive tPA for their stroke symptoms are at least 30 percent more likely to recover from their stroke with less disability after three months than those who present to the hospital after three hours and are thus unable to receive TPA

Ischemic strokes, the most common strokes, can be treated with a drug called tPA, which dissolves artery-obstructing clots. The window of opportunity to use TPA to treat stroke patients is 4.5 hrs, so the sooner stroke patients can get to the hospital to be evaluated and receive treatment, the better their outcome. Stroke patients who receive tPA for their stroke symptoms are at least 30 percent more likely to recover from their stroke with less disability after three months than those who present to the hospital after three hours and are thus unable to receive TPA

Ischemic strokes, the most common strokes, can be treated with a drug called tPA, which dissolves artery-obstructing clots. The window of opportunity to use TPA to treat stroke patients is 4.5 hrs, so the sooner stroke patients can get to the hospital to be evaluated and receive treatment, the better their outcome. Stroke patients who receive tPA for their stroke symptoms are at least 30 percent more likely to recover from their stroke with less disability after three months than those who present to the hospital after three hours and are thus unable to receive TPA

Ischemic strokes, the most common strokes, can be treated with a drug called tPA, which dissolves artery-obstructing clots. The window of opportunity to use TPA to treat stroke patients is 4.5 hrs, so the sooner stroke patients can get to the hospital to be evaluated and receive treatment, the better their outcome. Stroke patients who receive tPA for their stroke symptoms are at least 30 percent more likely to recover from their stroke with less disability after three months than those who present to the hospital after three hours and are thus unable to receive TPA

Ischemic strokes, the most common strokes, can be treated with a drug called tPA, which dissolves artery-obstructing clots. The window of opportunity to use TPA to treat stroke patients is 4.5 hrs, so the sooner stroke patients can get to the hospital to be evaluated and receive treatment, the better their outcome. Stroke patients who receive tPA for their stroke symptoms are at least 30 percent more likely to recover from their stroke with less disability after three months than those who present to the hospital after three hours and are thus unable to receive TPA

Courses Available At NTU

Sr. No. Name of Students Course Batch
1 Dr. Anand Tiwari IDCCM 2004
2 Dr. Patil Sudharshana IDCCM 2008
3 Dr. Pathak Manishprasad IDCCM 2008
4 Dr. Dhoot Varsha IDCCM 2008
5 Dr. Abhijeet M Deshmukh IDCCM 2009
6 Dr. Sushma Gurav IDCCM 2009
7 Dr. Natraj Sadaphule IDCCM 2009
8 Dr. Deepali Tambe IDCCM 2009
9 Dr. Praveen Gare IDCCM 2010
10 Dr. Anita Mohanty IDCCM 2010
11 Dr. Apoorva Mulley IDCCM 2011
12 Dr. Sanjay Warude IDCCM 2011
13 Dr. Lokesh Chopra IDCCM 2012
14 Dr. Pawan Bhujbal IDCCM 2012
15 Dr. Gauresh Palav IDCCM 2012
16 Dr. Manisha Patil / Bhosale 2 YRS Cert course 2012
17 Dr. Balaso Khot IDCCM 2013
18 Dr. Prasad Suryawanshi IDCCM 2013
19 Dr. Riddhi Vagela 2 YRS Cert course 2013
20 Dr. Sandip Patil 2 YRS Cert course 2014
21 Dr. Pallavi Meshram IDCCM 2014
22 Dr. Sourabh Ambadekar IDCCM 2014
23 Dr. Dipak Dhangar 2 YRS Cert course 2016
24 Dr. Achal Gaidhar 2 YRS Cert course 2016
25 Dr. Vishal Taur IDCCM 2016
26 Dr. Dilip Sawale IDCCM 2016
27 Dr. Amol Jawale 2 YRS Cert course 2016
28 Dr. Abhishek K IDCCM 2017
29 Dr. Pankaj Roy IDCCM 2017
30 Dr. Ria Malhotra 2 YRS Cert course 2017
31 Dr. Akashdeep Arora IDCCM 2017
32 Dr. Alka Verma IDCCM 2018
33 Dr. Priyanka Metgut IDCCM 2018
34 Dr. Ninad Gadre IDCCM 2018
35 Dr. Poornima Salakki 2 YRS Cert course 2018
36 Dr. Vitthal Alane 2 YRS Cert course 2018
37 Dr. Upendra Kapse IDCCM 2019
38 Dr. Ninad Bhosale IDCCM 2019
39 Dr. Sonika IDCCM 2021
40 Dr. Amol Jadhav IDCCM 2021
41 Dr. K V Nageshwara IDCCM 2021
42 Dr. Rohit Bhandari IDCCM 2022
43 Dr. Reshma Anjutdgi IDCCM 2022
44 Dr. Sohail Shaikh IDCCM 2022
45 Dr. Vinod Kute IDCCM 2022
46 Dr. Rashmi Ravindranathan IDCCM 2023
47 Dr. Samruddhi Wachasundar IDCCM 2023
48 Dr. Suhas Dhole IDCCM 2023
49 Dr. Devitha A IDCCM 2023
50 Dr. Chaitanya Murlidhar Bhujbal IDCCM 2024

Fellowship of The National Board

Sr. No. Name of Students Course Batch
1 Dr. Rahul Goyal FNB 2012
2 Dr. Prashant Ubale FNB 2013
3 Dr. Baljeet Kaur FNB 2014
4 Dr. Balkrishna Nimavat FNB 2015
5 Dr. Prasad Suryawanshi FNB 2016
6 Dr. Ramunaidu FNB 2016
7 Dr. Apeksha Parekh FNB 2017
8 Dr. Sushil Yadav FNB 2017
9 Dr. Amritha Varsheni FNB 2018
10 Dr. Rohit Garg FNB 2018
11 Dr. Afroz Khan FNB 2020
12 Dr. Abhaya Bhoyar FNB 2020
13 Dr. Piyush Dhawad FNB 2021
14 Dr. Hrushikesh Vaidya FNB 2021